| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| I1IQZ0 | Uncharacterized protein; | BRADI4G32830; | XP_003576638.1; | 739 | bromus |
| I1IRZ7 | Uncharacterized protein; | BRADI4G35600; | NULL | 246 | bromus |
| I1I6B5 | Uncharacterized protein; | BRADI3G33860; | XP_003574361.1; | 535 | bromus |
| I1J312 | Uncharacterized protein; | BRADI5G25180; | NULL | 481 | bromus |
| I1HM86 | Uncharacterized protein; | BRADI2G37090; | NULL | 374 | bromus |
| I1GNM1 | Purple acid phosphatase; EC 3.1.3.2; | BRADI1G09590; | XP_003560127.1; | 456 | bromus |
| I1H0U2 | Uncharacterized protein; | BRADI1G48697; | NULL | 1441 | bromus |
| I1I9M6 | Uncharacterized protein; | BRADI3G43290; | XP_003574963.1; | 377 | bromus |
| I1HXW9 | Flavin-containing monooxygenase; EC 1.-.-.-; | BRADI3G05867; | NULL | 472 | bromus |
| I1IC98 | Uncharacterized protein; | BRADI3G50730; | XP_003570031.1; | 264 | bromus |
| I1HIT5 | CASP-like protein; | BRADI2G23450; | XP_003568321.1; | 154 | bromus |
| I1H8Q3 | Uncharacterized protein; | BRADI1G71730; | NULL | 306 | bromus |
| I1HVV0 | Uncharacterized protein; | BRADI2G62650; | XP_003565195.1; | 384 | bromus |
| I1I8M4 | Auxin response factor; | BRADI3G40437; | NULL | 1041 | bromus |
| I1GMN6 | Inosine-5'-monophosphate dehydrogenase; IMP dehydrogenase; IMPD; IMPDH; EC 1.1.1.205; | BRADI1G06810; | XP_003558396.1; | 501 | bromus |
| I1HB32 | Uncharacterized protein; | BRADI2G00417; | XP_003568225.1; | 1283 | bromus |
| I1I7R4 | Nitrate reductase; | BRADI3G37940; | NULL | 891 | bromus |
| I1HBR7 | Uncharacterized protein; | BRADI2G02370; | XP_003565305.1; | 515 | bromus |
| I1HQN3 | Uncharacterized protein; | BRADI2G47360; | XP_003569619.1; | 1274 | bromus |
| I1HYD4 | Uncharacterized protein; | BRADI3G07190; | NULL | 269 | bromus |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |